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Trefoil factor family members (TFF1− 3) are small secretory
peptides on mucosal surfaces that regulate epithelial restitu-
tion and wound healing by promoting cell migration and
antagonising apoptosis. They have, in common, a structural
trefoil motif that is stabilised by three disulphide bonds. TFFs
are often co-secreted with mucins by mucin-producing cells,
helping to maintain epithelial integrity in normal tissue.1 TFF3
is constitutively expressed in the mammalian gastrointestinal
tract; however, upregulation of TFF3 expression frequently
observed in human colorectal tumour cells exerts pro-invasive
activity.2 Like other TFFs, TFF3 is regarded as a scatter factor,
which interferes with AKT, EGFR and Wnt/β-catenin
signalling.3 There is increasing evidence that these pathways
take an active part in progression of cancer 4 involving
non-coding RNAs (ncRNAs).
Only a few percent of themammalian genome are dedicated
to protein synthesis, but the remaining non-coding genome
either harbours important regulatory regions or encodes a
plethora of ncRNAs. The research on ncRNAs has incre-
ased tremendously during the last two decades, revealing
control of central cellular processes such as proliferation or
apoptosis in development and disease such as gastrointest-
inal malignancies.5 Research on microRNAs unveiled many
unresolved regulatory mechanisms, and it is more than likely
that RNAseq-based discovery and annotation of long
non-coding RNAs (lncRNAs) will accelerate this progress in
the future. Along these lines, a further level of regulatory RNA
networks governing cellular processes has been shown to
exist by interactions between microRNAs and lncRNAs or
pseudogenes.6
Bearing this in mind, and because many TFF3-relevant
signalling pathways have been reported to be controlled by
regulatory ncRNAs, we hypothesised that TFF3 may involve
regulatory networks of ncRNAs to exert its effects as a
scattering factor. In this context, in a recent study 7 we reported
that TFF3 exerts resistance to TNF-α /IFN-γ-triggered apop-
tosis in HT-29/B6 colorectal cancer cells by a signalling axis
including ncRNAs. Based on specific RT-qPCR experiments,
we identified several microRNAs and lncRNAs that were
differentially regulated by the expression of TFF3. Among
others, TFF3 reduces the expression of miR-491-5p in a
PI3K/AKT-dependent fashion, which in turn is able to interact
with and downregulate the lncRNA PRINS. The miR-491-5p/
PRINS-axis was shown to act as a master regulator of
apoptosis sensitivity in HT-29/B6 cells. PRINS detection by
fluorescence in situ hybridisation (FISH) revealed certain focal
signals in nuclei of HT-29/B6 cells. In search for targets or
interaction partners of PRINS, gain-of-function aswell as loss-
of-function experiments were performed, showing that the
cellular concentration of PMAIP1 (NOXA) depends on PRINS
availability. PMAIP1 is a pro-apoptotic protein known to recruit
MCL1 to mitochondria, causing its degradation. Interestingly
enough, in colorectal tumours PMAIP1 was detected both in
the cytosol and in the nuclei.8 Finally, combined immunofluor-
escence and FISH experiments showed co-localised PRINS
with PMAIP1 in nuclei of HT-29/B6 cells. Pull-down of PMAIP1
and co-precipitation of PRINS proved the interaction of both
molecules, prompting their cooperative function in the
nucleus. PRINS interacts either directly or together with
ribonucleoprotein complexes with PMAIP1. Experimental
reduction of PRINS causes PMAIP1 accumulation, suggest-
ing that PRINS acts as a decoy to retain PMAIP1 in the
nucleus, thereby prohibiting its pro-apoptotic activity in
the cytoplasm. Our ongoing studies are further resolving the
nuclear function of PMAIP1.
As mentioned above, TFF3 exerts its effects in a PI3K/AKT-
dependent fashion. Currently, our knowledge about receptors
for TFF peptides and how they trigger specific signalling is
limited. Previously, CXCR4 has been described as a low-
affinity TFF2 receptor.9 A more recent study reported that
CXCR4/7 heterodimers induce TFF3-dependent cellular
migration but not proliferation.10 Considering CXCR4 as a
potential TFF3 receptor, diverse signalling pathways may
contribute to miR-491-5p/PRINS/PMAIP1-mediated regula-
tion of apoptosis. Upon ligand binding CXCR4 may signal
through the PI3K-PDK1 cascade, finally activating P70-S6K
directly or via AKT (Figure 1). In our study, recently published
in Cell Death Discovery,7 we could show that chemical
inhibition of AKT resulted in increased expression of
miR-491-5p. On the other hand, TFF3 overexpression did
not change the phosphorylation states of PDK1 and AKT, but
changed P70-S6K. Otherwise, CXCR4 activation in metasta-
tic tumour cells was reported to activate small Rho-GTPases
such as CDC42.11 In this context, TFF3-CXCR4-mediated
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activation of small Rho-GTPases could have an effect on the
observed regulatory axis by PAK1-dependent activation of
MAPK.12 Moreover, since in our study TFF3 also influenced
cellular levels of PLCG2, a potential role of CXCR4-dependent
PLCG/PKC signalling has to be taken into account (Figure 1).
Furthermore, silencing of CXCR7 was shown to induce
apoptosis in a β-arrestin- and ERK-dependent fashion.13
However, whether β-arrestin and ERK pathway are involved in
TFF3-dependent regulation of apoptosis in colon cancer
progression and metastasis has still to be addressed.
In conclusion, our study7 provides further evidence that
networks of ncRNAs together with involved ribonucleoprotein
complexes present a wealth of unprecedented mechanisms
that persistently revolutionise our understanding of important
cellular processes, such as apoptosis and autophagy.
Moreover, translational research on ncRNAs will provide
targets for novel therapeutic strategies to combat, for example,
resistance of malignancies to TRAIL-directed therapies or
multi-drug-resistant bacterial infections.
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Figure 1 Model of potential TFF3-induced signalling pathways mediating miR-491-5p/PRINS-axis. Based on our results and data from literature the following modes of TFF3
action can be postulated. Potential binding of TFF3 to CXCR4 is considered to signal through PI3K/AKT, small Rho-GTPases, PLCG/PKC or β-arrestin-ERK. While our studies
have demonstrated PI3K/AKT to act via miR-491-5p/PRINS to trigger apoptosis, other CXCR4-dependent signalling cascades remain to be explored
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